Biomarin Pharmaceutical Inc (BMRN)
66.60
+0.71
(+1.08%)
USD |
NASDAQ |
Nov 01, 16:00
66.60
0.00 (0.00%)
After-Hours: 20:00
Biomarin Pharmaceutical Market Cap: 12.69B for Nov. 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 12.69B |
| October 31, 2024 | 12.56B |
| October 30, 2024 | 12.71B |
| October 29, 2024 | 13.32B |
| October 28, 2024 | 13.37B |
| October 25, 2024 | 13.29B |
| October 24, 2024 | 13.41B |
| October 23, 2024 | 13.33B |
| October 22, 2024 | 13.44B |
| October 21, 2024 | 13.39B |
| October 18, 2024 | 13.36B |
| October 17, 2024 | 13.24B |
| October 16, 2024 | 13.37B |
| October 15, 2024 | 13.43B |
| October 14, 2024 | 13.39B |
| October 11, 2024 | 13.41B |
| October 10, 2024 | 13.31B |
| October 09, 2024 | 13.30B |
| October 08, 2024 | 13.09B |
| October 07, 2024 | 13.14B |
| October 04, 2024 | 13.25B |
| October 03, 2024 | 12.99B |
| October 02, 2024 | 13.27B |
| October 01, 2024 | 13.36B |
| September 30, 2024 | 13.39B |
| Date | Value |
|---|---|
| September 27, 2024 | 13.44B |
| September 26, 2024 | 13.37B |
| September 25, 2024 | 13.14B |
| September 24, 2024 | 13.23B |
| September 23, 2024 | 13.16B |
| September 20, 2024 | 13.46B |
| September 19, 2024 | 13.60B |
| September 18, 2024 | 13.54B |
| September 17, 2024 | 13.43B |
| September 16, 2024 | 13.30B |
| September 13, 2024 | 16.16B |
| September 12, 2024 | 16.06B |
| September 11, 2024 | 16.14B |
| September 10, 2024 | 16.15B |
| September 09, 2024 | 16.05B |
| September 06, 2024 | 16.01B |
| September 05, 2024 | 16.21B |
| September 04, 2024 | 17.11B |
| September 03, 2024 | 17.44B |
| August 30, 2024 | 17.36B |
| August 29, 2024 | 17.40B |
| August 28, 2024 | 17.20B |
| August 27, 2024 | 17.22B |
| August 26, 2024 | 17.13B |
| August 23, 2024 | 17.14B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
12.56B
Minimum
Oct 31 2024
23.74B
Maximum
Jul 20 2020
16.10B
Average
15.90B
Median
Market Cap Benchmarks
| Merck & Co Inc | 258.25B |
| Bristol-Myers Squibb Co | 110.17B |
| Alnylam Pharmaceuticals Inc | 35.33B |
| Bioventus Inc | 883.74M |
| Moderna Inc | 21.00B |
Market Cap Related Metrics
| PE Ratio | 39.88 |
| PS Ratio | 4.750 |
| PEG Ratio | 0.3401 |
| Price to Book Value | 2.345 |
| Price to Free Cash Flow | 43.46 |
| Price | 66.60 |
| Earnings Yield | 2.51% |
| PEGY Ratio | 0.3401 |
| Operating PE Ratio | 41.86 |
| Normalized PE Ratio | 40.91 |